Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Aug 5;23(4):21br02930.
doi: 10.4088/PCC.21br02930.

Prevalence of Kratom Use and Co-Occurring Substance Use Disorders in the United States

Kevin Y Xu  1   2 , Carrie M Mintz  1 , Jacob T Borodovsky  1   3 , Paul E A Glaser  4 , Laura J Bierut  1   5 , Richard A Grucza  1   6
Affiliations

Prevalence of Kratom Use and Co-Occurring Substance Use Disorders in the United States

Kevin Y Xu et al. Prim Care Companion CNS Disord. .
No abstract available

PubMed Disclaimer

References

    1. Anwar M, Law R, Schier J. Notes from the Field. Kratom (Mitragyna speciosa) Exposures Reported to Poison Centers — United States, 2010–2015. MMWR Morb Mortal Wkly Rep. 2016.;65:748–749. - PubMed
    1. Schimmel J, Amioka E, Rockhill K, et al. Prevalence and description of kratom (Mitragyna speciosa) use in the United States: a cross-sectional study. Addiction. 2020. - PubMed
    1. Grundmann O. Patterns of Kratom use and health impact in the US-Results from an online survey. Drug Alcohol Depend. 2017;176:63–70. - PubMed
    1. Veltri C, Grundmann O. Current perspectives on the impact of Kratom use. Subst Abuse Rehabil. 2019;10:23–31. - PMC - PubMed
    1. Prozialeck WC, Avery BA, Boyer EW, et al. Kratom policy: the challenge of balancing therapeutic potential with public safety. Int J Drug Policy. 2019; 70: 70–77. - PMC - PubMed

MeSH terms

Substances